Seres Therapeutics, Inc. (MCRB) stock
MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 18, 2026Market cap $14.32MP/E –Yield –
Seres Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Seres Therapeutics's pe ratio was 11.5× on Apr 30, 2026, against 617.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 11.5× | −13.7 |
| 2025 | Dec 31, 2025 | 25.2× | – |
See a number that looks wrong?